Gemcitabine for Advanced Endometrial Cancer

International Journal of Gynecological Cancer - United Kingdom
doi 10.1097/igc.0b013e31824a33a2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Cost-Effectiveness of Gemcitabine Plus Cisplatin Versus Gemcitabine Alone for Treatment of Advanced Biliary Tract Cancer in Japan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Efficacy of Metformin for Advanced-Stage Endometrial Cancer: A Case Report

Molecular and Clinical Oncology
Cancer ResearchOncology
2017English

Biweekly Cisplatin and Gemcitabine in Patients With Advanced Biliary Tract Cancer

International Journal of Cancer
Cancer ResearchOncology
2017English

Bevacizumab Combined With Gemcitabine and Capecitabine for Advanced Pancreatic Cancer: A Phase II Study

British Journal of Cancer
Cancer ResearchOncology
2009English

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2015English

Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer

Clinical Cancer Research
Cancer ResearchOncology
2018English

Predictors for Resectability and Survival in Locally Advanced Pancreatic Cancer After Gemcitabine-Based Neoadjuvant Therapy

Pancreatology
EndocrinologyHepatologyMetabolismGastroenterologyDiabetes
2016English

Timing of Chemotherapy-Induced Neutropenia: The Prognostic Factor in Advanced Pancreatic Cancer Patients Treated With Gemcitabine / Gemcitabine-Based Chemotherapy

Oncotarget
Oncology
2017English

Phase I Dose-Escalation Study of Copanlisib in Combination With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy